PriceTargets.com logo

Trulieve Cannabis - TRLV Stock Price Target and Predictions

  • Consensus Rating: Hold
  • Consensus Price Target: $15.00
  • Forecasted Upside: 74.03%
  • Number of Analysts: 3
  • Breakdown:
  • 1 Sell Ratings
  • 1 Hold Ratings
  • 1 Buy Ratings
  • 0 Strong Buy Ratings
$8.62 As of 07/31/2026 04:59 PM ET
▲ +0.049 (0.57%)

This chart shows the closing price for TRLV by one month, three months, or twelve months.

Skip Closing Price Chart
1 month | 3 months | 12 months
Get New Trulieve Cannabis Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for TRLV and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for TRLV

Analyst Price Target is $15.00
▲ +74.03% Upside Potential
This price target is based on 3 analysts offering 12 month price targets for Trulieve Cannabis in the last 3 months. The average price target is $15.00, with a high forecast of $15.00 and a low forecast of $15.00. The average price target represents a 74.03% upside from the last price of $8.62.

This chart shows the closing price for TRLV for the last year in relation to the current analyst high, average, and low pricetarget.

Read Analyst Price Chart DescriptionSkip Analyst Price Chart




Current Consensus is Hold

The current consensus among 3 contributing investment analysts is to hold stock in Trulieve Cannabis. This rating changed within the last month from a Reduce consensus rating.

Past Monthly Recommendations

Move your mouse over past months for details

Read Past Recommendations DescriptionSkip Past Price Target Consensus Chart
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
2/7/2025
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
5/8/2025
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
8/6/2025
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
11/4/2025
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
2/2/2026
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
5/3/2026
  • 0 strong buy ratings
  • 0 buy ratings
  • 1 hold ratings
  • 1 sell ratings
Ratings as of
7/2/2026
  • 0 strong buy ratings
  • 1 buy ratings
  • 1 hold ratings
  • 1 sell ratings
Ratings as of
8/1/2026

Latest Recommendations

  • 0 strong buy ratings
  • 1 buy ratings
  • 1 hold ratings
  • 1 sell ratings

Display Ratings By
DateBrokerageActionRatingPrice TargetDetails
7/20/2026Cantor FitzgeraldInitiated CoverageOverweight$15.00
6/18/2026Zacks ResearchUpgradeHold
6/16/2026Weiss RatingsInitiated CoverageSell (D-)
(Data available from 8/1/2021 forward)

News Sentiment Rating

0.68 (Buy)

Our news sentiment rating is based on the average sentiment of articles about this company published in the media in the last 30 days of headlines and can range from 2 (very positive sentiment) to -2 (very negative sentiment).

News Sentiment Over Time

Move your mouse over past months for details

Skip to Current Sentiment Summary
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
1/3/2026
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
2/2/2026
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
3/4/2026
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
4/3/2026
  • 0 very positive mentions
  • 1 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
5/3/2026
  • 0 very positive mentions
  • 1 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
6/2/2026
  • 4 very positive mentions
  • 4 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
7/2/2026
  • 3 very positive mentions
  • 5 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
8/1/2026

Current Sentiment

  • 3 very positive mentions
  • 5 positive mentions
  • 0 negative mentions
  • 0 very negative mentions

Recent Stories by Sentiment

Very Negative

  • No very negative mentions tracked during this time.

Negative

  • No negative mentions tracked during this time.

Positive

Very Positive

Trulieve Cannabis logo
Trulieve Cannabis Corp., together with its subsidiaries, operates as a medical cannabis company. The company cultivates and produces products in-house and distributes its products to Trulieve branded stores (dispensaries) in Florida, California, Massachusetts, Connecticut, Pennsylvania, and West Virginia, as well as directly to patients through home delivery. It produces approximately 550 stock keeping units, including flower, edibles, vaporizer cartridges, concentrates, topicals, capsules, tinctures, dissolvable powders, and nasal sprays. As of May 5, 2021, the company operated through 87 dispensaries in the United States. The company is headquartered in Quincy, Florida.
Read More

Today's Range

Now: $8.62
Low: $8.20
High: $8.68

50 Day Range

MA: N/A

52 Week Range

Now: $8.62
Low: $4.19
High: $13.28

Volume

711,430 shs

Average Volume

641,277 shs

Market Capitalization

$1.66 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

N/A

Frequently Asked Questions

What sell-side analysts currently cover shares of Trulieve Cannabis?

The following Wall Street research analysts have issued stock ratings on Trulieve Cannabis in the last year: Cantor Fitzgerald, Wall Street Zen, Weiss Ratings, and Zacks Research.
View the latest analyst ratings for TRLV.

What is the current price target for Trulieve Cannabis?

0 Wall Street analysts have set twelve-month price targets for Trulieve Cannabis in the last year. Their average twelve-month price target is $15.00, suggesting a possible upside of 74.0%. Cantor Fitzgerald has the highest price target set, predicting TRLV will reach $15.00 in the next twelve months. Cantor Fitzgerald has the lowest price target set, forecasting a price of $15.00 for Trulieve Cannabis in the next year.
View the latest price targets for TRLV.

What is the current consensus analyst rating for Trulieve Cannabis?

Trulieve Cannabis currently has 1 sell rating, 1 hold rating and 1 buy rating from Wall Street analysts. The stock has a consensus analyst rating of "Hold." A "hold" rating indicates that analysts believe investors should keep any existing positions they have in TRLV, but not buy more shares or sell existing shares.
View the latest ratings for TRLV.

What other companies compete with Trulieve Cannabis?

Other companies that are similar to Trulieve Cannabis include Xenon Pharmaceuticals, Belite Bio, PTC Therapeutics, Erasca and Scholar Rock. Learn More about companies similar to Trulieve Cannabis.

How do I contact Trulieve Cannabis' investor relations team?

Trulieve Cannabis' physical mailing address is 6749 BEN BOSTIC ROAD, QUINCY, FL, 32351. The company's listed phone number is (850) 298-8866. The official website for Trulieve Cannabis is trulieve.com. Learn More about contacing Trulieve Cannabis investor relations.